Massachusetts Financial Services Co. MA Has $158.51 Million Stake in Humana Inc. (NYSE:HUM)

Massachusetts Financial Services Co. MA boosted its position in Humana Inc. (NYSE:HUM - Free Report) by 59.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 624,756 shares of the insurance provider's stock after purchasing an additional 233,099 shares during the period. Massachusetts Financial Services Co. MA owned about 0.52% of Humana worth $158,507,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. FPC Investment Advisory Inc. purchased a new position in shares of Humana in the fourth quarter valued at $27,000. Centricity Wealth Management LLC purchased a new position in Humana during the 4th quarter valued at about $30,000. LFA Lugano Financial Advisors SA raised its position in Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after acquiring an additional 45 shares during the last quarter. OFI Invest Asset Management acquired a new position in Humana during the fourth quarter worth about $33,000. Finally, Atwood & Palmer Inc. grew its position in shares of Humana by 64.5% in the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock valued at $39,000 after purchasing an additional 60 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Price Performance

Shares of HUM traded up $0.05 during mid-day trading on Thursday, hitting $285.58. The company's stock had a trading volume of 659,645 shares, compared to its average volume of 1,739,591. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a 50-day moving average price of $265.60 and a 200 day moving average price of $270.92. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The stock has a market capitalization of $34.47 billion, a price-to-earnings ratio of 28.66, a PEG ratio of 2.05 and a beta of 0.62.

Remove Ads

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.24%. The ex-dividend date is Friday, March 28th. Humana's payout ratio is currently 35.58%.

Wall Street Analyst Weigh In

HUM has been the topic of a number of recent research reports. Piper Sandler upped their target price on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research note on Wednesday, January 15th. Guggenheim assumed coverage on Humana in a research note on Wednesday. They set a "buy" rating and a $326.00 price objective on the stock. Morgan Stanley reduced their target price on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a report on Wednesday, February 12th. Truist Financial lifted their price target on shares of Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a report on Monday, January 6th. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Seventeen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $284.25.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.